anti-immunoglobulin-beta CAR T Cells
Term · Oncology and biomedicine · MLC-T-ONC-010821
A preparation of T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) targeting immunoglobulin-beta (Igb), with potential immunostimulating and antineoplastic activities. Upon administration, the anti-Igb CAR T cells are directed to, specifically bind to, and induce selective toxicity in Igb antigen-expressing tumor cells.
| Identifier | MLC-T-ONC-010821 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-Igb CAR T cells; shRNA-IL-6-modified anti-CD19 CAR-T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010821",
"term": "anti-immunoglobulin-beta CAR T Cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) targeting immunoglobulin-beta (Igb), with potential immunostimulating and antineoplastic activities. Upon administration, the anti-Igb CAR T cells are directed to, specifically bind to, and induce selective toxicity in Igb antigen-expressing tumor cells.",
"synonyms": [
"anti-Igb CAR T cells",
"shRNA-IL-6-modified anti-CD19 CAR-T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-immunoglobulin-beta-car-t-cells/"
}
Record 1,936 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.